Insight Molecular Diagnostics Inc. Common Stock IMDX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$50.22M+17.2% | -$60.66M-118% | -$27.78M+61.9% | -$72.9M-13.7% | ||
| $2.19M+48.4% | $1.48M-7.3% | $1.59M+4.2% | $1.53M+81.0% | ||
| $2.22M+26.6% | $1.75M-36.5% | $2.76M-72.5% | $10.04M+46.8% | ||
| -$22.18M-7.2% | -$20.69M+11.3% | -$23.33M+48.8% | -$45.57M-26.8% | ||
| $3.19M+517% | $516K— | —— | $4.34M+93.1% | ||
| -$3.19M-522% | -$512K— | —— | -$4.34M+68.9% | ||
| —— | $20.68M— | —— | —— | ||
| —— | —— | —— | -$14.1M— | ||
| -$25.37M-19.6% | -$21.21M— | —— | -$49.91M-30.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insight Molecular Diagnostics Inc. Common Stock generate?
- Insight Molecular Diagnostics Inc. Common Stock (IMDX) generated -$24.0M in operating cash flow over the trailing twelve months.
- What is Insight Molecular Diagnostics Inc. Common Stock's free cash flow?
- After $3.5M of capital expenditures, Insight Molecular Diagnostics Inc. Common Stock's free cash flow was -$27.5M over the trailing twelve months, down 16.9% year over year.
- Where does Insight Molecular Diagnostics Inc. Common Stock's cash flow data come from?
- Every line is extracted from Insight Molecular Diagnostics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
